Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
D-Sight Logo
D-Sight Growth Score
82
CB Rank
68602
Heat Score
47
D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
Founded
obfuscation
PrivateSeed Barcelona, Catalonia, Spain1-10 www.dsight.es/
Biotechnology
Health Care
Overview

D-Sight
Total Funding
obfuscation
Growth Score
82
Heat Score
47

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score82
-11 pts
in past quarter
Heat Score 47
-34 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About D-Sight

CB Rank
68602
D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
Founded
obfuscation
PrivateSeed Barcelona, Catalonia, Spain1-10 www.dsight.es/
Biotechnology
Health Care

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Details

Legal Name D-Sight S.L.
Operating Status Active
Company Type For Profit
About the Company
D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
Contact Email info@dsight.es
Predictions & Insights

Growth Insight

See this Growth Insight
D-Sight is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Topical Ocular DPP-IV Inhibitor Eye Drops for Early Diabetic Retinopathy
A non-invasive eye drop formulation using DPP-IV inhibitors to prevent and treat early stages of diabetic retinopathy by increasing retinal GLP-1 levels and protecting retinal neurons and microvasculature.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - D-Sight Logo
Seed Round - D-Sight
4
obfuscation
Clave CapitalSeed
obfuscation
Seed Round - D-Sight Logo
Seed Round - D-Sight
4
obfuscation
Clave CapitalSeed
obfuscation
Seed Round - D-Sight Logo
Seed Round - D-Sight
4
obfuscation
Clave CapitalSeed
obfuscation
Seed Round - D-Sight Logo
Seed Round - D-Sight
4
obfuscation
Clave CapitalSeed
obfuscation
Seed Round - D-Sight Logo
Seed Round - D-Sight
4
obfuscation
Clave CapitalSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - D-Sight Logo
Seed Round - D-Sight
4
obfuscation
Clave CapitalSeed
obfuscation
Seed Round - D-Sight Logo
Seed Round - D-Sight
4
obfuscation
Clave CapitalSeed
obfuscation
Seed Round - D-Sight Logo
Seed Round - D-Sight
4
obfuscation
Clave CapitalSeed
obfuscation
Seed Round - D-Sight Logo
Seed Round - D-Sight
4
obfuscation
Clave CapitalSeed
obfuscation
Seed Round - D-Sight Logo
Seed Round - D-Sight
4
obfuscation
Clave CapitalSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•Feb 23, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 23, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

240
66.67%
 in past month

IT Spend

$264.1KThis year, D-Sight is projected to spend $264.1K on IT, according to Aberdeen.

Active Website Tech Count

4D-Sight is actively using 4 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.

Total IP

1D-Sight has 1 registered trademark in the 'Scientific and technological services' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is D-Sight's headquarters? D-Sight is located in Barcelona, Catalonia, Spain.Who invested in D-Sight? D-Sight has 4 investors including Prous Institute for Biomedical Research and  Bio Angels Club.When was the last funding round for D-Sight? D-Sight closed its last funding round on
obfuscation
from a Seed round.Who are D-Sight's competitors? Alternatives and possible competitors to D-Sight may include AdhexPharma.How much funding has D-Sight raised to date? D-Sight has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(64a2f73 1)
|